From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady sits down with Mesoblast Director Silviu Itescu, to unpack the recent approval and launch of their Ryoncil drug for children, their outlook for the next 12 months in capturing the adult market, and their extensive pipeline of further products.

Weekly Wrap 13 September

Bell Direct
September 13, 2024

Morning Bell 13 September

Bell Direct
September 13, 2024

Morning Bell 12 September

Bell Direct
September 12, 2024

8 minutes with 8 executives

Bell Direct
September 11, 2024

Morning Bell 11 September

Bell Direct
September 11, 2024

Morning Bell 10 September

Bell Direct
September 10, 2024

Morning Bell 9 September

Bell Direct
September 9, 2024

Weekly Wrap 6 September

Bell Direct
September 6, 2024

Morning Bell 5 September

Sam Kanaan
September 5, 2024

Morning Bell 4 September

Bell Direct
September 4, 2024

Morning Bell 3 September

Bell Direct
September 3, 2024

Morning Bell 2 September

Bell Direct
September 2, 2024